Ieq Capital LLC Takes $11.73 Million Position in The Cooper Companies, Inc. $COO

Key Points

• Ieq Capital LLC acquired 163,614 shares of Cooper Companies in the second quarter, establishing a position worth approximately $11.73 million, or 0.08% of the company.
• Cooper Companies reported quarterly EPS of $1.21, exceeding estimates by $0.11, while revenue rose 7.9% year over year to $1.08 billion. Analysts expect full-year EPS of approximately $4.63.
• Analyst sentiment is mixed: the stock has a consensus “Hold” rating and an average price target of $81.64, compared with a recent opening price of $76.22.

Ieq Capital LLC bought a new stake in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 163,614 shares of the medical device company's stock, valued at approximately $11,733,000. Ieq Capital LLC owned approximately 0.08% of Cooper Companies at the end of the most recent quarter.

A number of other institutional investors have also added to or reduced their stakes in the company. Avalon Trust Co acquired a new stake in Cooper Companies in the second quarter valued at $25,000. Root Financial Partners LLC increased its stake in shares of Cooper Companies by 104.5% during the 4th quarter. Root Financial Partners LLC now owns 317 shares of the medical device company's stock worth $26,000 after purchasing an additional 162 shares during the last quarter. SJS Investment Consulting Inc. increased its stake in shares of Cooper Companies by 107.5% during the 1st quarter. SJS Investment Consulting Inc. now owns 361 shares of the medical device company's stock worth $26,000 after purchasing an additional 187 shares during the last quarter. Elevation Wealth Partners LLC raised its holdings in shares of Cooper Companies by 1,136.4% in the 2nd quarter. Elevation Wealth Partners LLC now owns 408 shares of the medical device company's stock valued at $29,000 after purchasing an additional 375 shares during the period. Finally, J.Safra Asset Management Corp bought a new stake in shares of Cooper Companies in the 2nd quarter valued at about $32,000. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Cooper Companies Price Performance

Cooper Companies stock opened at $76.22 on Friday. The company has a current ratio of 1.27, a quick ratio of 0.78 and a debt-to-equity ratio of 0.23. The stock's 50 day moving average is $71.93 and its 200-day moving average is $71.16. The Cooper Companies, Inc. has a 12 month low of $58.89 and a 12 month high of $89.83. The company has a market capitalization of $14.87 billion, a price-to-earnings ratio of 64.59, a PEG ratio of 1.99 and a beta of 0.83.

Cooper Companies (NASDAQ:COO - Get Free Report) last posted its quarterly earnings data on Thursday, June 4th. The medical device company reported $1.21 earnings per share for the quarter, topping the consensus estimate of $1.10 by $0.11. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The firm had revenue of $1.08 billion for the quarter, compared to analysts' expectations of $1.05 billion. During the same quarter last year, the business earned $0.96 EPS. The company's quarterly revenue was up 7.9% compared to the same quarter last year. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Equities research analysts expect that The Cooper Companies, Inc. will post 4.63 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on COO shares. Wall Street Zen upgraded Cooper Companies from a "hold" rating to a "buy" rating in a report on Sunday, June 21st. BNP Paribas Exane lowered their price target on Cooper Companies from $95.00 to $92.00 and set an "outperform" rating on the stock in a research report on Monday, June 8th. Stifel Nicolaus dropped their price objective on Cooper Companies from $95.00 to $85.00 and set a "buy" rating on the stock in a research note on Friday, June 5th. Piper Sandler set a $86.00 price objective on Cooper Companies and gave the company an "overweight" rating in a research report on Monday, June 1st. Finally, Mizuho set a $85.00 target price on Cooper Companies and gave the stock an "outperform" rating in a research note on Thursday, June 4th. One analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, six have issued a Hold rating and three have given a Sell rating to the stock. Based on data from MarketBeat, Cooper Companies presently has a consensus rating of "Hold" and a consensus target price of $81.64.

Cooper Companies Company Profile

Cooper Companies, Inc NASDAQ: COO is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women's health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cooper Companies, Inc. (NASDAQ:COO - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source